Literature DB >> 21617691

Antithrombotic therapy. Lancelot results published.

Bryony M Mearns.   

Abstract

Year:  2011        PMID： 21617691     DOI： 10.1038/nrcardio.2011.76

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial.

Authors:  Stephen D Wiviott; Marcus D Flather; Michelle L O'Donoghue; Shinya Goto; Desmond J Fitzgerald; Fernando Cura; Philip Aylward; Victor Guetta; Dariusz Dudek; Charles F Contant; Dominick J Angiolillo; Deepak L Bhatt
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

2.  Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.

Authors:  Michelle L O'Donoghue; Deepak L Bhatt; Stephen D Wiviott; Shaun G Goodman; Desmond J Fitzgerald; Dominick J Angiolillo; Shinya Goto; Gilles Montalescot; Uwe Zeymer; Philip E Aylward; Victor Guetta; Dariusz Dudek; Rafal Ziecina; Charles F Contant; Marcus D Flather
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.